{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-211548","form_type":"8-K","ticker":"EBS","cik":"0001367644","company_name":"Emergent BioSolutions Inc.","filed_at":"2024-09-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.799300+00:00","generated_at":"2026-05-31T06:35:38.013237+00:00","sec_items":["1.01","1.02","2.03","3.02","7.01","8.01","9.01"],"event_type":"debt","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Emergent BioSolutions closes $250M term loan with Oak Hill Advisors; extends maturity to 2029","bullets":["$250M term loan drawn in full, matures August 2029; used to repay existing senior term loan due May 2025 and terminate revolver.","Issued warrants for 2.5M shares at 110% and 175% of 30-day VWAP; agreed to issue $10M in common stock at VWAP.","Interest at SOFR+8.25% or Base Rate+7.25%; default rate +2%; covenants include $75M minimum liquidity and leverage ratio tests.","New facility expected to reduce net debt by >$200M in 2024; management cites greater operational flexibility for turnaround.","Oak Hill Advisors serves as lead agent; company to participate in Wells Fargo and H.C. Wainwright conferences in September."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-211548","json":"https://secwatch.observer/filing/0001193125-24-211548.json","markdown":"https://secwatch.observer/filing/0001193125-24-211548.md","text":"https://secwatch.observer/filing/0001193125-24-211548.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1367644/000119312524211548/0001193125-24-211548-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1367644/000119312524211548/d873622d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T06:35:38.013237+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}